Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Meredith Schultz"'
Autor:
Arne Mueller, Elaine Paterson, Avery McIntosh, Jens Praestgaard, Mary Bylo, Holger Hoefling, McKenzie Wells, David R. Lynch, Christian Rummey, Michelle L. Krishnan, Meredith Schultz, C. J. Malanga
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 8, Iss 9, Pp 1845-1856 (2021)
Abstract Background Friedreich’s ataxia is an inherited, progressive, neurodegenerative disease that typically begins in childhood. Disease severity is commonly assessed with rating scales, such as the modified Friedreich’s Ataxia Rating Scale, w
Externí odkaz:
https://doaj.org/article/4bb3e0bbb3164dd9951988e35f7802ba
Autor:
Matthew A. Halanski, Rewais Hanna, James Bernatz, Max Twedt, Sarah Sund, Karen Patterson, Kenneth J. Noonan, Meredith Schultz, Mary K. Schroth, Mark Sharafinski, Brian P. Hasley
Publikováno v:
Children, Vol 8, Iss 8, p 703 (2021)
This is a retrospective radiographic review to assess post-operative sagittal plane deformities in patients with Spinal Muscular Atrophy type 2 that had been treated with posterior spinal instrumentation. Thirty-two patients with a history of either
Externí odkaz:
https://doaj.org/article/79ae67acead040ec912139c50e5a2550
Autor:
Meredith Schultz, Alexandra Durr, Carine Karachi, Michael O’Callaghan, Sandro Alves, Alain Lamontagne, Hortense Hurmic, Nathalie Cartier
Publikováno v:
Sunday, April 23.
Autor:
David A. Lynch, Michelle L. Krishnan, Mary Bylo, Arne Mueller, Holger Hoefling, Jens Praestgaard, Elaine Paterson, Christian Rummey, McKenzie Wells, C J Malanga, Avery McIntosh, Meredith Schultz
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 8, Iss 9, Pp 1845-1856 (2021)
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology
Background Friedreich's ataxia is an inherited, progressive, neurodegenerative disease that typically begins in childhood. Disease severity is commonly assessed with rating scales, such as the modified Friedreich's Ataxia Rating Scale, which are usua
Autor:
Matthew A. Halanski, Mary K. Schroth, Scott Hetzel, Meredith Schultz, Mark Sharafinski, Karen Patterson, Rewais Hanna, Sarah Sund, Kenneth J. Noonan
Publikováno v:
Spine Deformity. 8:547-552
Single center, retrospective chart review. To determine if routine posterior spinal fusion (PSF) is unnecessary in non-ambulatory growing rod graduates with SMA. Most non-ambulatory children with SMA develop early-onset scoliosis (EOS). Posterior gro
Autor:
Karen Patterson, Matthew A. Halanski, Meredith Schultz, Mary K. Schroth, Sarah Sund, Rewais Hanna, Meaghann S. Weaver, Scott Hetzel, Alice Yuroff
Publikováno v:
Journal of Child Neurology. 35:322-330
Background: Spinal muscular atrophy is an autosomal-recessive, progressive neuromuscular disease associated with extensive morbidity. Children with spinal muscular atrophy have potentially increased life spans due to improved nutrition, respiratory s
Autor:
Sitra Tauscher-Wisniewski, Thomas O. Crawford, Susan T. Iannaccone, Claudia A. Chiriboga, Basil T. Darras, John W. Day, Anne M. Connolly, Richard S. Finkel, I Kausar, Edward C. Smith, L.D.M. Peña, Jerry R. Mendell, Nancy L. Kuntz, Thomas A. Macek, Meredith Schultz, D Chand, Jennifer M. Kwon, Craig M. Zaidman, H. Ouyang, Perry B. Shieh
Publikováno v:
Predicting longer term outcomes in children.
Introduction and Objective Onasemnogene abeparvovec (formerly AVXS-101), is designed to address the genetic root cause of spinal muscular atrophy (SMA), survival motor neuron 1 gene (SMN1) deletion/mutation. Here, we evaluate final data from STR1VE-U
Autor:
Jerry R. Mendell, Meredith Schultz, Douglas M. Sproule, Haojun Ouyang, Claudia A. Chiriboga, Loren D M Pena, John W. Day, Craig M. Zaidman, Anne M. Connolly, Susan T. Iannaccone, Thomas O. Crawford, Basil T. Darras, Nancy L. Kuntz, Deepa H. Chand, Edward C. Smith, Thomas A Macek, Perry B. Shieh, Sitra Tauscher-Wisniewski, Douglas E. Feltner, Richard S. Finkel, Jennifer M. Kwon
Publikováno v:
The Lancet. Neurology. 20(4)
Summary Background Spinal muscular atrophy type 1 is a motor neuron disorder resulting in death or the need for permanent ventilation by age 2 years. We aimed to evaluate the safety and efficacy of onasemnogene abeparvovec (previously known as AVXS-1
Autor:
Thomas A. Macek, Edward C. Smith, John W. Day, Perry B. Shieh, S.T. Iannaconne, H. Ouyang, Anne M. Connolly, Richard Shell, Craig M. Zaidman, J. Mendell, Douglas M. Sproule, Thomas O. Crawford, Sitra Tauscher-Wisniewski, Claudia A. Chiriboga, Meredith Schultz, L.D.M. Peña, Richard S. Finkel, Basil T. Darras, Francis G. Ogrinc, P. Thomasma, Jennifer M. Kwon, Douglas E. Feltner, Nancy L. Kuntz, Elaine Kernbauer
Publikováno v:
C96. BEST OF PEDIATRICS.
Autor:
Richard S. Finkel, Nancy L. Kuntz, John W. Day, Perry B. Shieh, Anne M. Connolly, Elaine Kernbauer, James L’Italien, Brian K. Kaspar, Francis G. Ogrinc, Richard Shell, L.D.M. Peña, Douglas M. Sproule, Edward C. Smith, Claudia A. Chiriboga, Douglas E. Feltner, Meredith Schultz, Susan T. Iannaccone, Jerry R. Mendell, Thomas O. Crawford, Basil T. Darras, I Kausar, Thomas A. Macek
Publikováno v:
Diagnostic and therapeutic advances in paediatrics.
Introduction and objectives SMA1 is a rapidly progressing neurologic disease caused by biallelic loss/mutation of the survival motor neuron 1 gene (SMN1). Onasemnogene abeparvovec (formerly AVXS-101) is a one-time GRT designed to treat the genetic ro